Budesonide MMX 6 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Budesonide MMX 6 mg, covering 2020-08-17 to 2020-08-17. Get the full timeline:
Most recent: Clinical Trial Update: (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis. [Phase 3]